AVNS
Avanos Medical Inc
25.00$
+0.0%
vs. previous close
Closing price · As of: Jul 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -56.4% | -163.0% | – | -17.3% | +151.7% | -55.6% | -73.5% | +105.9% | +101.4% | -143.6% | – | |
| – | -4.3% | +4.5% | -0.9% | -0.9% | +3.5% | -5.1% | -13.5% | +4.2% | -6.0% | +5.3% | +3.0% | – | |
| – | +0.0% | +2.6% | -10.0% | +5.6% | -31.6% | +46.2% | +0.0% | +7.9% | -14.6% | -65.7% | +208.3% | – | |
| – | -98.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -116.5% | – | – | -55.4% | +1,116.2% | -88.0% | -225.9% | – | – | -228.2% | – | |
| – | -2.5% | +51.3% | -30.5% | +43.9% | -49.2% | +60.0% | +39.6% | +64.2% | -36.4% | -1.4% | -37.7% | – | |
| – | +652.3% | – | -102.5% | +195.0% | +103.4% | -36.7% | +19.7% | +45.1% | +138.6% | -78.4% | +13.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +253.8% | -32.6% | +46.8% | -61.5% | -97.1% | +0.0% | +2,100.0% | -63.6% | -100.0% | – | +333.3% | – | |
| – | – | – | – | – | – | +106.8% | +0.0% | -91.2% | -4.2% | +4.3% | -4.2% | – | |
| – | – | -345.6% | -99.4% | +614.3% | +220.0% | +71.2% | +6.2% | -89.0% | -37.5% | +35.0% | +18.5% | – | |
| – | – | -176.7% | – | – | -119.5% | – | -157.2% | – | – | – | -225.4% | – | |
| – | – | -73.0% | -277.9% | – | -8.7% | +165.5% | -64.2% | -122.1% | – | +204.3% | -177.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.